Meet the next evolution of ddPCR solutions
Monday, October 27, at 15:00 BST | 16:00 CEST | 10:00 EDT | 7:00 PDT
This webinar will explore the insights from the ddPCR World on Tour event in London and introduce the next evolution of Droplet Digital™ PCR (ddPCR™) technology. You’ll hear directly from fellow researchers and pioneers in the field as they share how ddPCR has advanced their studies, from detecting rare mutations to improving transplant monitoring. Plus, discover how Bio-Rad’s latest systems deliver exceptional sensitivity, simplicity, and performance, enabling absolute quantification, scalable workflows, and reliable results with minimal sample input.
Key learning objectives:
- Explore the latest ddPCR innovations and how they improve sensitivity, reproducibility, and ease of use.
- Hear about practical applications of ddPCR, from rare mutation detection to transplant monitoring.
- Gain real-world insights through user testimonials on how ddPCR has advanced their research.
The session will conclude with a Q&A, giving you the chance to ask our experts questions directly and gain practical insights to apply to your own research. Don’t miss this opportunity to see how ddPCR can transform your experiments.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
A postdoctoral research fellow at the University of Warwick with a Ph.D. in Medicine, M.Sc. by Research in Medical Sciences and B.Sc. in Biological and Chemical Sciences (First Class Honours). Dr. Chow-Seng Kong has developed new biomarker-based tests for reproductive failure which helps to improve pregnancy outcomes, which are currently in patent review. Experienced in a broad range of techniques in the field of adherent/suspension cell culture, molecular biology, and bioinformatic data analysis.
A second-year Trainee Clinical Scientist on the NHS’ Scientist Training Programme (STP), specializing in histocompatibility and immunogenetics (H&I), also known as tissue typing. The three-year program combines work-based clinical training with an M.Sc. degree in Clinical Science, which includes a research project.
A Senior Research Fellow at University College London, working with Dr. Giandomenico Turchiano and Professor Adrian Thrasher on gene therapy approaches for primary immunodeficiency disorders. This research primarily addresses safety considerations associated with designer nuclease-mediated gene editing. Specifically, it is focused on developing innovative, high-sensitivity platforms for quantifying genomic aberrations and assessing genome integrity post-editing. Using these platforms, they also elucidate fundamental mechanisms of designer nuclease activity and DNA repair pathways.
Moderator
